Achieve Life Sciences Inc


Prices are adjusted according to historical splits.

Achieve Life Sciences Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$90.38 million
Book Value:
Revenue TTM:
Operating Margin TTM:
Gross Profit TTM:
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Achieve Life Sciences Inc had its IPO on 1995-10-13 under the ticker symbol ACHV.

The company operates in the Healthcare sector and Biotechnology industry. Achieve Life Sciences Inc has a staff strength of 16 employees.

Stock update

Shares of Achieve Life Sciences Inc opened at $4.54 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $4.27 - $4.7, and closed at $4.35.

This is a -2.03% slip from the previous day's closing price.

A total volume of 248,500 shares were traded at the close of the day’s session.

In the last one week, shares of Achieve Life Sciences Inc have slipped by -12.12%.

Achieve Life Sciences Inc's Key Ratios

Achieve Life Sciences Inc has a market cap of $90.38 million, indicating a price to book ratio of 44.2283 and a price to sales ratio of 0.

In the last 12-months Achieve Life Sciences Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-36820000. The EBITDA ratio measures Achieve Life Sciences Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Achieve Life Sciences Inc’s operating margin was 0% while its return on assets stood at -75.28% with a return of equity of -214.13%.

In Q3, Achieve Life Sciences Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Achieve Life Sciences Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-4.15 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Achieve Life Sciences Inc’s profitability.

Achieve Life Sciences Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.1913. Its price to sales ratio in the trailing 12-months stood at 0.

Achieve Life Sciences Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$23.72 million
Total Liabilities
$6.92 million
Operating Cash Flow
Capital Expenditure
Dividend Payout Ratio

Achieve Life Sciences Inc ended 2023 with $23.72 million in total assets and $0 in total liabilities. Its intangible assets were valued at $23.72 million while shareholder equity stood at $1.04 million.

Achieve Life Sciences Inc ended 2023 with $0 in deferred long-term liabilities, $6.92 million in other current liabilities, 79000.00 in common stock, $-124704000.00 in retained earnings and $1.03 million in goodwill. Its cash balance stood at $18.20 million and cash and short-term investments were $18.20 million. The company’s total short-term debt was $23,000 while long-term debt stood at $15.76 million.

Achieve Life Sciences Inc’s total current assets stands at $20.96 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $145000.00 compared to accounts payable of $412000.00 and inventory worth $0.

In 2023, Achieve Life Sciences Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Achieve Life Sciences Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Achieve Life Sciences Inc stock is currently trading at $4.35 per share. It touched a 52-week high of $8.13 and a 52-week low of $8.13. Analysts tracking the stock have a 12-month average target price of $24.75.

Its 50-day moving average was $4.74 and 200-day moving average was $4.17 The short ratio stood at 5.76 indicating a short percent outstanding of 0%.

Around 841.2% of the company’s stock are held by insiders while 3338.7% are held by institutions.

Frequently Asked Questions About Achieve Life Sciences Inc

The stock symbol (also called stock or share ticker) of Achieve Life Sciences Inc is ACHV

The IPO of Achieve Life Sciences Inc took place on 1995-10-13

Similar Industry Stocks (Biotechnology)

Last Price
Compass Inc (COMP)
Keyera Corp (KEYUF)

Most Active

Last Price

Top Gainers

Last Price

Top Losers

Last Price


Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.


1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1